Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513786
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2007-08-08
Brief Title:
Evaluation of CarboplatinPaclitaxelBevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Sponsor:
David OMalley
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-06133
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
David OMalley
Lead Sponsor Class:
OTHER
Responsible Party:
David OMalley
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |